PA) – Jonathan A. Epstein, MD, has been appointed
Chair of the Department of Cell and Developmental Biology, effective
April 1, 2006.
“Dr. Epstein is considered one of the world’s leading
investigators of the molecular mechanisms of cardiovascular development
and their implications for understanding human disease,” said
Dr. Arthur Rubenstein, Executive Vice President
of the University of Pennsylvania for the Health System and Dean
of the School of Medicine. “I have the utmost
confidence that Dr. Epstein is an excellent choice. His record of
excellence and depth of experiences will serve him well in this
A Professor of Medicine in PENN's School of Medicine with a secondary
appointment as a Professor of Cell and Developmental Biology, he
has held the William Wickoff Smith Chair in Cardiovascular Research
since 2004. Jon came to Penn in 1996 as an Assistant Professor and
quickly rose through the ranks. He has published more than 75 scientific
articles during his time at Penn and has been recognized nationally
and internationally for his accomplishments. This year, he was selected
for the prestigious Outstanding Investigator Award from the American
Federation for Medical Research, its highest honor, and he was elected
to the American Association of Physicians, one of our nation’s
most prestigious societies for academic physicians. He is a member
and a councilor of the American Society of Clinical Investigation.
Dr. Epstein has consistently sought to translate discoveries in
basic science into knowledge that has clinical applications. He
received the Clinician Investigator Development Award from the National
Heart, Lung, and Blood Institute, as well as the McCabe Fellow Award
for research that bridges clinical and basic sciences. In the same
vein, Dr. Epstein headed the Clinical Investigator Pathway in the
Department of Medicine’s residency program from 2001 to 2005.
Dr. Epstein is an Established Investigator of the American Heart
Association. At Penn, Dr. Epstein is widely known for his commitment
to teaching, both in the Cardiac Intensive Care Unit, in medical
school classes, and as a director and lecturer in graduate seminars
in Genetics and Developmental Biology. He has been very involved
in several multidisciplinary centers and institutes, including the
Abramson Cancer Center, the Pennsylvania Muscle Institute, the Graduate
Group in Cell and Molecular Biology, the Institute for Medicine
and Engineering, the Center for Research on Reproduction and Women’s
Health, and the Wistar Institute. He has directed the Program in
Molecular Cardiology since 2001 and was named Scientific Director
of the new Penn Cardiovascular Institute in 2005.
Dr. Epstein received his BA and MD degrees from Harvard and completed
his residency and cardiology fellowship training at Brigham and
Women’s Hospital. He then received funding from the Howard
Hughes Medical Institute to perform postdoctoral research in Genetics
before coming to Penn in 1996.
PENN Medicine is a $2.9 billion enterprise
dedicated to the related missions of medical education, biomedical
research, and high-quality patient care. PENN Medicine consists
of the University of Pennsylvania School of Medicine (founded in
1765 as the nation's first medical school) and the University of
Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt
of NIH research funds; and ranked #3 in the nation in U.S.News &
World Report's most recent ranking of top research-oriented medical
schools. Supporting 1,400 fulltime faculty and 700 students, the
School of Medicine is recognized worldwide for its superior education
and training of the next generation of physician-scientists and
leaders of academic medicine.
The University of Pennsylvania Health System includes three
hospitals [Hospital of the University of Pennsylvania, which is
consistently ranked one of the nation's few "Honor Roll"
hospitals by U.S.News & World Report; Pennsylvania Hospital,
the nation's first hospital; and Penn Presbyterian Medical Center];
a faculty practice plan; a primary-care provider network; two multispecialty
satellite facilities; and home care and hospice.